Cinitapride, also known as Cinitapride Tartrate, is a novel prokinetic benzamide-stimulating gastrointestinal motility agent and antiulcer agent. It acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors, making it a promising pharmaceutical candidate for various applications.
Used in Pharmaceutical Industry:
Cinitapride is used as a prokinetic agent for stimulating gastrointestinal motility, which helps in the treatment of various gastrointestinal disorders such as gastroparesis, constipation, and irritable bowel syndrome. Its agonistic action on 5-HT1 and 5-HT4 receptors promotes smooth muscle contraction and peristalsis, leading to improved gastrointestinal function.
Cinitapride is also used as an antiulcer agent for the treatment and prevention of peptic ulcers. Its antagonistic action on 5-HT2 receptors helps in reducing gastric acid secretion and protecting the gastric mucosa, thereby promoting ulcer healing and reducing the risk of ulcer recurrence.
Furthermore, Cinitapride's dual action on 5-HT receptors makes it a potential candidate for the treatment of other gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and functional dyspepsia, where its prokinetic and antiulcer properties can be beneficial.
Used in Pharmaceutical Industry:
Cinitapride is used as a prokinetic agent for stimulating gastrointestinal motility, which helps in the treatment of various gastrointestinal disorders such as gastroparesis, constipation, and irritable bowel syndrome. Its agonistic action on 5-HT1 and 5-HT4 receptors promotes smooth muscle contraction and peristalsis, leading to improved gastrointestinal function.
Cinitapride is also used as an antiulcer agent for the treatment and prevention of peptic ulcers. Its antagonistic action on 5-HT2 receptors helps in reducing gastric acid secretion and protecting the gastric mucosa, thereby promoting ulcer healing and reducing the risk of ulcer recurrence.
Furthermore, Cinitapride's dual action on 5-HT receptors makes it a potential candidate for the treatment of other gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and functional dyspepsia, where its prokinetic and antiulcer properties can be beneficial.
96623-56-2
Post Buying Request-
-
Basic information
- Product Name: CINITAPRIDE
- Synonyms: Benzamide, 4-amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitro-, (2R,3R)-2,3-dihydroxybutanedioate(1:1);Cinitapride;4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitrobenzamide (2R,3R)-2,3-dihydroxybutanedioate;Blaston;Pemix
- CAS NO:96623-56-2
- Molecular Formula: C25H36N4O10
- Molecular Weight: 552.57414
- EINECS: N/A
- Product Categories: N/A
- Mol File: 96623-56-2.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: Refrigerator
- Solubility: Acetone (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
- CAS DataBase Reference: CINITAPRIDE(CAS DataBase Reference)
- NIST Chemistry Reference: CINITAPRIDE(96623-56-2)
- EPA Substance Registry System: CINITAPRIDE(96623-56-2)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 96623-56-2(Hazardous Substances Data)
96623-56-2 Suppliers
Recommended suppliers
96623-56-2 Usage
Check Digit Verification of cas no
The CAS Registry Mumber 96623-56-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,6,2 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.Calculate Digit Verification of CAS Registry Number 96623-56:
(7*9)+(6*6)+(5*6)+(4*2)+(3*3)+(2*5)+(1*6)=162
162 % 10 = 2
So 96623-56-2 is a valid CAS Registry Number.
96623-56-2Upstream product
96623-56-2Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 96623-56-2
CINITAPRIDE
